CVS CVS HEALTH Earnings and EPS analysis

EPS in 2025 (TTM): $4.2

Last Report Period Date: Mar 31, 2025

As of June 2025, according to CVS HEALTH's latest financial report, the company's current EPS (TTM) is $4.2. In 2024, the company recorded an earnings per share (EPS) of $3.67, which represents a decrease compared to its EPS of $6.49 in 2023. CVS HEALTH's earnings per share for the quarterly report ending on Mar 31, 2025 was $1.41.

The annual EPS in 2024 was $3.67, a decrease of 43.5% from $6.49 in 2023. For the quarter ending Mar 31, 2025, the EPS was $1.41, showing a 60.2% increase from the same quarter last year. The trailing twelve months (TTM) EPS as of March 2025 is $4.2. In 2023, the annual EPS was $6.49, showing an increase of 97.3% from 2022.

Over the last 12 months, CVS HEALTH has registered an EPS growth of 60.2% (YoY, quarterly). Over a three-year span, the company had an average EPS growth of -15.4% per year. Over the last 5 years, the company had an average EPS growth rate of -6.4%. When measured over a ten-year period, CVS's average EPS growth rate was -0.8%.